98 Drug Safety courses delivered Online

As a healthcare professional or a patient, medication safety is crucial for ensuring effective healthcare delivery.Look no further! Our Medication Errors: Prevention and Management course is designed to equip you with the knowledge and skills necessary to ensure safe administration, storage, supply, and disposal of medications. With a focus on key principles of medication management and patient involvement in medication safety, this course will prepare you to communicate effectively with colleagues and patients, handle hazardous drugs safely, and maintain accurate records. Enrol now and become an expert in medication safety and management. Learning Outcomes: Understand the importance of safe medication management Comply with relevant legislation and licensing requirements Communicate effectively with colleagues and patients about medication safety Administer medications safely and accurately Involve patients in medication safety and management Store, supply, and dispose of medication safely Handle hazardous drugs safely Maintain accurate records and participate in audit processes Medication safety is crucial for healthcare professionals, patients, and their families. Our Medication Errors: Prevention and Management course provides a comprehensive overview of safe medication management. You will learn about key principles of medication management, including legislation and licensing requirements, communication and professional etiquette, safe administration, and patient involvement in medication safety. You will also learn about the storage, supply, and disposal of medication, as well as the safe handling of hazardous drugs. Finally, you will learn about record-keeping and audit processes to ensure continuous improvement in medication safety. Whether you are a healthcare professional or a patient or a caregiver, this course will equip you with the knowledge and skills to ensure safe medication management. Certification Upon completion of the Medication Errors: Prevention and Management course, learners can obtain a certificate as proof of their achievement. You can receive a £4.99 PDF Certificate sent via email, a £9.99 Printed Hardcopy Certificate for delivery in the UK, or a £19.99 Printed Hardcopy Certificate for international delivery. Each option depends on individual preferences and locations. CPD 10 CPD hours / points Accredited by CPD Quality Standards Who is this course for? Healthcare professionals, including nurses, doctors, and pharmacists, who want to improve their medication management skills and ensure patient safety. Patients and caregivers who want to learn about safe medication management and become active participants in their own care. Individuals who are interested in pursuing a career in healthcare or medication management. Anyone who wants to learn about safe medication management and contribute to a safer healthcare system. Career path After completing this course, you will have the knowledge and skills necessary to pursue a career in healthcare or medication management. Some potential job titles include: Medication Safety Officer: £35,000 - £60,000 per year Clinical Pharmacist: £26,000 - £50,000 per year Nursing Coordinator: £25,000 - £45,000 per year Patient Safety Manager: £30,000 - £60,000 per year

An Investigational New Drug Application (IND) is a submission to the US Food and Drug Administration (FDA) for permission to conduct a clinical trial of a medicinal product. This module describes regulatory requirements that sponsors or sponsor-investigators must meet for successful compilation, filing and maintenance of INDs. The IND and its role are defined, and the contexts in which it is required are specified.

Good Clinical Practice (GCP) is a set of internationally recognised ethical and scientific quality requirements for designing, conducting, recording and reporting clinical trials. Compliance with GCP principles is required by regulatory authorities in many countries for the authorisation of clinical trials and the acceptance of their data. The International Council for Harmonisation’s guideline E6, often referred to as ICH GCP, is the international standard specification for Good Clinical Practice.

To conduct a clinical trial in the European Economic Area under the Clinical Trials Directive the sponsor must apply for authorisation from the national competent authority (i.e. medicines regulator), and favourable opinion must be obtained from a research ethics committee, in each member state in which the trial is to take place. This module sets out the requirements for successful compilation, submission and maintenance of the applications.

The New Drug Application (NDA) is the regulatory vehicle through which sponsors formally propose that the Food and Drug Administration (FDA) approve a new pharmaceutical for marketing and sale in the USA.

This module aims to provide you with effective strategies for the preparation and conduct of a clinical trial, while adhering to regulatory safety standards. Management of data for submission is also covered.

The module describes general principles of GCP inspection and audit, discusses preparation for an inspection, and sets out in detail what European and US FDA inspectors will examine. Finally it describes post-inspection actions by the regulator and the inspected party.

The eCTD is mandatory for all applications for marketing approval and all subsequent related submissions in the European Economic Area, the USA and Canada. Other countries intend to make its use mandatory. The eCTD specification has been developed to facilitate the global electronic submission, review and lifecycle management of medicinal product dossiers for regulatory applications. It broadens the scope of the CTD to include information on variations, renewals and amendments, so that it is no longer a static document but is updatable throughout the life of the product. This module outlines the eCTD specification, discusses the approach to regional differences in dossiers, and provides guidance on creation of an eCTD submission. The module provides a training and reference tool that will be of particular value to those new to the use of the format.

This module describes the requirements that must be met to obtain licensure of a biological product. Subjects covered include the regulatory context, the content and format of the BLA submission, the review process, and provisions for expedited development and review.

Having undergone Installation Qualification, before equipment can be used routinely in production, it needs to undergo Operational Qualification (OQ) and Performance Qualification (PQ). This module describes OQ and PQ requirements and procedures in the medicines and healthcare products industries. It follows the activities of a typical validation team as they carry out a project for a pharmaceutical company.